- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05599620
Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma (AWARE)
April 27, 2026 updated by: Lindsay Orchowski Ph.D., Lifespan
The goal of this clinical trial is to develop and evaluate the preliminary efficacy of an intervention to address alcohol use, sexual distress, and sexual assault risk among college women with a history of sexual victimization.
The main questions it aims to answer are: 1) what is the feasibility of the recruitment method, research design, interventionist training methods, and delivery of the intervention; 2) does the intervention, relatively to control, the 2- and 4-month follow-up produces reductions in the quantity/frequency of alcohol use and heavy drinking, sexual distress, and sex-related drinking motives, and sexual revictimization.
Participants will engage in both individual and group based intervention for alcohol use, sexual distress, and sexual assault risk.
Follow-up assessments are completed at 2- and 4-months following program completion.
The intervention is compared to a wait list control group who will have the opportunity to complete the program after completing the 4-month follow up.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02904
- Rhode Island Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 24 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- be between the ages of 18 and 24;
- speak and comprehend English;
- report a history of attempted or completed penetrative or non-penetrative acts of sexual victimization (i.e., oral, vaginal, anal) since age 14 via incapacitation, coercion, or force;
- report exceeding the national recommended limits for daily drinking (4 or more for women) on one or more occasions in the past 6 months;
- report past year sexual activity;
- exceed the clinical cut point on the Female Sexual Functioning Index (score of 28.1 or lower) or exceed the cut point for the 13-item Female Sexual Distress Scale-Revised (score of 11 or higher)
Exclusion Criteria:
- suicide risk on items from the Beck Depression Inventory;
- screen positive on the Alcohol Use Withdrawal Checklist.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AWARE Program
The AWARE program addresses alcohol use, sexual distress and sexual revictimization risk.
|
AWARE addresses alcohol use, sexual distress, and sexual assault risk among college women with a history of sexual victimization.
|
|
No Intervention: Control Group
The comparison is a wait list control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol Use
Time Frame: Change from baseline alcohol use at 4 months.
|
The number of past month drinking days (Minmum = 0, Maximum = 30), average drinks per drinking day (Minmum = 0, Maximum = unspecificed), number of heavy drinking days (Minimum = 0, Maximum = 30), assessed via the Time Line Follow Back, with greater scores meaning worse outcomes.
|
Change from baseline alcohol use at 4 months.
|
|
Sexual Distress
Time Frame: Change from overall levels of sexual dysfunction at 4 months.
|
Assessed via the Female Sexual Dysfunction Index, Minimum = 2, Maximum = 36 with higher scores meaning worse outcomes, and the Female Sexual Distress Scale, Minimum = 0, Maximum = 52 with lower scores meaning worse outcomes.
|
Change from overall levels of sexual dysfunction at 4 months.
|
|
Sexual Victimization
Time Frame: Reductions in severity and frequency of victimization in comparison to control at 4 months.
|
Assessed via the Sexual Experiences Survey.
Scored based on frequency and severity, Minumum = 0, Maximum = 63, higher scores means worse outcomes.
|
Reductions in severity and frequency of victimization in comparison to control at 4 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sex-Related Drinking Expectancies
Time Frame: Change in sexual related drinking expectancies at 4 months.
|
Assessed via the Sex Related Alcohol Expectancies, Minimum = 14, Maximum = 70
|
Change in sexual related drinking expectancies at 4 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 14, 2023
Primary Completion (Actual)
March 30, 2026
Study Completion (Actual)
March 30, 2026
Study Registration Dates
First Submitted
October 25, 2022
First Submitted That Met QC Criteria
October 28, 2022
First Posted (Actual)
October 31, 2022
Study Record Updates
Last Update Posted (Actual)
April 29, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34AA028402 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be shared using the National Institute of Mental Health Data Archive (NDA).
IPD Sharing Time Frame
The research team will submit data on or before the NDA submission due dates (April 1 and October 1 each year) in accordance with the applicable Data Sharing Terms and Conditions of award.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.